Jundishapur Journal of Microbiology

Published by: Kowsar

The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains

Joanna Kwiecinska-Pirog 1 , Krzysztof Skowron 1 , * , Wojciech Bartczak 1 and Eugenia Gospodarek-Komkowska 1
Authors Information
1 Department of Microbiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum of L. Rydygier in Bydgoszcz, Bydgoszcz, Poland
Article information
  • Jundishapur Journal of Microbiology: April 01, 2016, 9 (4); e32656
  • Published Online: April 23, 2016
  • Article Type: Research Article
  • Received: August 27, 2015
  • Revised: December 23, 2015
  • Accepted: January 29, 2016
  • DOI: 10.5812/jjm.32656

To Cite: Kwiecinska-Pirog J, Skowron K, Bartczak W, Gospodarek-Komkowska E. The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains, Jundishapur J Microbiol. 2016 ; 9(4):e32656. doi: 10.5812/jjm.32656.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Manos J, Belas R. The Genera Proteus, Providencia, and Morganella. 2006; : 245-69[DOI]
  • 2. Rozalski A, Kwil I, Torzewska A, Baranowska M, Staczek P. Proteus bacilli: features and virulence factors. Postepy Hig Med Dosw (Online). 2007; 61: 204-19[PubMed]
  • 3. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews. 2008; 21(1): 26-59[DOI]
  • 4. Billewicz-Kraczkowska A, Kulik-Rechberger B, Furmaga-Jabłońska, W. . A noninvasive treatment of multiple brain abscesses in the course of neonatal cerebrospinal meningitis with Proteus mirabilis as etiological agent : A case study. Child Neurology. 2007; 16(31): 51-4
  • 5. Reslinski, A. , Mikucka, A. , Szczęsny, W. , Szmytkowski, J. , Gospodarek, E. , Dabrowiecki, S. . Wykrywanie biofilmu in vivo na powierzchni siatki chirurgicznej -opis przypadku. Chir Pol. 2008; 10(1-2): 181-8
  • 6. Kokare CR, Chakraborty S, Khopade AN, Mahadik KR. Biofilm: Importance and applications. Ind J Biotechnology. 2009; 8(2): 159-68
  • 7. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4): 322-32[DOI]
  • 8. Breakpoint tables for interpretation of MICs and zone diameters 2014;
  • 9. CLSI Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2015;
  • 10. Kwiecinska-Pirog J, Skowron K, Zniszczol K, Gospodarek E. The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms. Biomed Res Int. 2013; 2013: 930876[DOI][PubMed]
  • 11. Gales AC, Sader HS, Jones RN. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997–2000). Diagnostic Microbiology and Infectious Disease. 2002; 44(3): 289-99[DOI]
  • 12. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, Giovanoli P. Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986–2005). Burns. 2009; 35(4): 553-60[DOI]
  • 13. Hernandez JR, Martinez-Martinez L, Pascual A, Suarez AI, Perea EJ. Trends in the susceptibilities of Proteus mirabilis isolates to quinolones. Journal of Antimicrobial Chemotherapy. 2000; 45(3): 407-8[DOI]
  • 14. Ko KS, Lee MY, Song JH, Lee H, Jung DS, Jung SI, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis. 2008; 61(4): 453-9[DOI][PubMed]
  • 15. Sohn KM, Kang C, Joo EJ, Ha YE, Chung DR, Peck KR, et al. Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum β-Lactamase Production inProteus mirabilisBacteremia. Korean J Intern Med. 2011; 26(1): 89[DOI]
  • 16. Saito R, Okugawa S, Kumita W, Sato K, Chida T, Okamura N, et al. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients. Clin Microbiol Infect. 2007; 13(12): 1204-6[DOI][PubMed]
  • 17. Wagenlehner FME, Niemetz A, Dalhoff A, Naber KG. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrobial Agents. 2002; 19(6): 557-64[DOI]
  • 18. Yah SC, Eghafona NO, Oranusi S, Abouo AM. Widespread plasmid resistance genes among Proteus species in diabetic wounds of patients in the Ahmadu Bello university teaching hospital (ABUTH) Zaria. Afr J Biotechnol. 2007; 6(15)
  • 19. Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol. 2014; 7(1)[DOI]
  • 20. Kanayama A, Kobayashi I, Shibuya K. Distribution and antimicrobial susceptibility profile of extended-spectrum beta-lactamase-producing Proteus mirabilis strains recently isolated in Japan. Int J Antimicrob Agents. 2015; 45(2): 113-8[DOI][PubMed]
  • 21. Myszka K, Czaczyk K. Effect of starvation stress on morphological changes and production of adhesive exopolysaccharide (EPS) by Proteus vulgaris. Acta Sci Pol. 2015; 10(3): 305-12[DOI]
  • 22. Azizi O, Shakibaie MR, Modarresi F, Shahcheraghi F. Molecular detection of class-D OXA carbapenemase genes in biofilm and non-biofilm forming clinical isolates of Acinetobacter baumannii. Jundishapur J Mircobiol. 2015; 8(1)[DOI]
  • 23. Ali OAU. Prevention of Proteus mirabilis biofilm by surfactant solution. Egypt Acad J of Biol Sci. 2012; 4: 1-8
  • 24. Aniejurengho OUV, Dessi M, Meikle S, Santin M, Okoli I. Biofilm formation in uropathogenic strains of Proteus mirabilis and their susceptibility to poly (epsilon-lysine) dendron. Biosci Res Today World. 2015; 1(1): 1-9
  • 25. Arabski M, Wasik S, Zych M, Lakomiec W, Kaca W. Analysis of ciprofloxacin and gentamicin diffusion in Proteus mirabilis O18 biofilm by laser interferometry method. Acta Biochim Pol. 2013; 60(4): 707-11[PubMed]
  • 26. Shafiei M, Abdi Ali A, Shahcheraghi F, Saboora A, Akbari Noghabi K. Eradication of Pseudomonas aeruginosa Biofilms Using the Combination of n-butanolic Cyclamen coum Extract and Ciprofloxacin. Jundishapur J Microbiol. 2014; 7(2)[DOI]
  • 27. Bellifa S, Hassaine H, Balestrino D, Charbonnel N, M’hamedi I, Terki IK, et al. Evaluation of biofilm formation of Klebsiella pneumoniae isolated from medical devices at the University Hospital of Tlemcen, Algeria. Afr J Microbiol Res. 2013; 7(49): 5558-64
  • 28. Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010; 65(9): 1955-8[DOI]
  • 29. Wasfi R, Abd El-Rahman OA, Mansour LE, Hanora AS, Hashem AM, Ashour MS. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Indian J Med Microbiol. 2012; 30(1): 76-80[DOI][PubMed]
  • 30. Oldak E, Trafny EA. Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin. Antimicrob Agents Chemother. 2005; 49(8): 3281-8[DOI][PubMed]
  • 31. Wojnicz D, Tichaczek-Goska D. Effect of sub-minimum inhibitory concentrations of ciprofloxacin, amikacin and colistin on biofilm formation and virulence factors of Escherichia coli planktonic and biofilm forms isolated from human urine. Braz J Microbiol. 2013; 44(1): 259-65[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments